Tag Archives: self-regulation

Seminar: The Advertising of Therapeutic Good and Services, March 17, 2016

Introduction This seminar was held back-to-back with World Consumer Rights Day 2016 (March 15) and the National Consumer Congress (March 16). The latter was hosted by the Australian Competition and Consumer Commission (ACCC). The 2016 Congress discussed how to better protect … Continue reading

Posted in Chiropractic, Complementary medicine, Education, Natural Therapies, Pharmaceutical Promotion | Tagged , , , , , , , , | 2 Comments

ABC RN Interview – Drug company marketing on doctor’s choices

This interview with Michael Mackenzie (ABC Radio National, Friday 28th August, 2015, 14:40 minutes) can be heard here. It was based on a recent lecture given to Monash University pharmacology students. by

Posted in Education, Pharmaceutical Promotion, Uncategorized | Tagged , , | Leave a comment

Drug promotion, advertising and ethical relationships with industry

Gave a lecture on this topic to Monash pharmacology students on August 21, 2015. A PDF version is available here. by

Posted in Pharmaceutical Promotion | Tagged , , , , | 1 Comment

Australian docs who accept pharma money must be named – ACCC

Australia’s competition and consumer watchdog (ACCC) has demanded that drug companies publicly name any doctor who accepts consultancy or speaker fees or free travel and accommodation. Unless this condition is complied with the ACCC will not authorise Medicines Australia’s latest … Continue reading

Posted in Uncategorized | Tagged , , , | Leave a comment

How well does Australia control the promotion of therapeutic goods?

Yesterday, I gave an invited presentation to TGA staff in Canberra (and elsewhere by video-link).  I reviewed how well Australia had implemented the 2007 World Health Assembly’s (WHA) Resolution 60.16: “Wishing to promote evidence-based rational use of medicines by providers and consumers, … Continue reading

Posted in Pharmaceutical Promotion | Tagged , , , , , , , | 1 Comment

Medicines Australia Transparency Working Group Releases Reports

The documents, “Principles for transparency” and “Transparency model consultation and discussion document” are now available. For comment see: Harvey K. Slow path to transparency. MJA Insight, July 1, 2013. https://www.mja.com.au/insight/2013/24/ken-harvey-slow-path-transparency Coleman J. GPs will gain from greater transparency. 6 Minutes Q&A, July … Continue reading

Posted in Pharmaceutical Promotion | Tagged , , | Leave a comment

Therapeutic Goods Amendment (Pharmaceutical Transparency) Bill 2013 torpedoed

See: http://theconversation.com/pharma-payments-to-doctors-stay-behind-closed-doors-for-now-15279 by

Posted in Pharmaceutical Promotion, Senate | Tagged , , | Leave a comment

Transcripts now available: Therapeutic Goods Amendment (Pharmaceutical Transparency) Bill 2013

See: Finance and Public Administration Legislation Committee; Monday, 29 April 2013 by

Posted in Pharmaceutical Promotion, Senate | Tagged , | Leave a comment

Melbourne Senate Public Hearing: Therapeutic Goods Amendment (Pharmaceutical Transparency) Bill 2013

On Monday, April 29, 2013 I’m appearing before a  Senate committee to give evidence about this bill put up by Greens Senator Richard Di Natale. The committee is looking at the need for regulation of pharmaceutical industry conduct with regards to interactions with the … Continue reading

Posted in Pharmaceutical Promotion, Senate | Tagged , | Leave a comment

Submission re Senate Therapeutic Goods Amendment (Pharmaceutical Transparency) Bill 2013

Now posted on the Senate web site along with others. Today is the last day for submissions so I guess more will show up next week. by

Posted in Pharmaceutical Promotion, Senate | Tagged , | Leave a comment